To gain further insight into the changes in anti-apoptotic signaling in human gastric adenocarcinoma, the changes in BNIP3, Bcl-2 and X-linked inhibitor of apoptosis (XIAP) were determined by immunoblotting. This evidence concerns the gene BCL2 and gastric adenocarcinoma.